Related Experiment Video

Updated: Nov 7, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

641

Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy

Maxime Teisseyre1,2, Sonia Boyer-Suavet2,3,4, Marion Crémoni3

  • 1Laboratoire d'Immunologie, CHU de Nice, Université Côte d'Azur, France.

Kidney International Reports
|April 29, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

33.8K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.0K

Related Experiment Videos

Last Updated: Nov 7, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

641
The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

33.8K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.0K

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

162
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
162
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

86
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
86

Articles linked to this work by shared authors, journal, and citation graph.

Incidence and implications of anti-rituximab antibodies in nephropathies and other immune-mediated diseases: a narrative review.

Frontiers in immunology·2026

Characterisation of the Novel HLA-A*32:207 Allele by Sequencing-Based Typing.

HLA·2026

Characterisation of the Novel HLA-C*07:01:139 Allele by Sequencing-Based Typing.

HLA·2026

Outcomes and Predictors of Treatment Response in Patients With Pure Lupus Membranous Nephropathy.

Kidney international reports·2026

Characterisation of the Novel HLA-DRB1*13:386 Allele by Sequencing-Based Typing.

HLA·2026

Regulatory T-cells technology and vascularized composite allotransplantation: A scoping review.

Transplant immunology·2026

Life Participation in Parents of Children With CKD.

Kidney international reports·2026

Eicosanoids as Biomarkers of Hyperfiltration-Mediated Injury in CKD.

Kidney international reports·2026

Renal Outcomes in Hereditary Fibrinogen A Alpha-Chain Amyloidosis.

Kidney international reports·2026

Multimodal Profiling of Complement Expression and Association With Outcomes in ANCA-Associated Vasculitis With Glomerulonephritis.

Kidney international reports·2026

Kidney Transcatheter Arterial Embolization Reduces Kidney Cyst Infection in Patients With ADPKD.

Kidney international reports·2026

Targeting the B-Cell Activating Factor and a Proliferation-Inducing Ligand Pathway in IgAN: From Disease Pathogenesis to Clinical Trial Evidence.

Kidney international reports·2026

One-Year Outcomes of PreserFlo MicroShunt implantation Using Intraoperative Sub-Tenon Triamcinolone Acetonide.

Clinical ophthalmology (Auckland, N.Z.)·2026

Ocular morbidity in uveal melanocytoma associated with MEN1 syndrome.

American journal of ophthalmology case reports·2026

Peptide-Mediated Precise Intracellular Delivery of Bioactive Substances.

International journal of nanomedicine·2026

Long-acting injectables for global health: drug development considerations and applications in malaria and tuberculosis.

Gates open research·2026

Integrative m6A epitranscriptomic and transcriptomic analysis in livers of patients with type 2 diabetes mellitus.

Genomics·2026

Probiotic-loaded biomaterial for wound healing and tissue regeneration: a unique medical tool.

International journal of pharmaceutics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us